Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.5302
-0.0038 (-0.71%)
At close: Sep 4, 2025, 4:00 PM
0.5278
-0.0024 (-0.45%)
After-hours: Sep 4, 2025, 7:59 PM EDT

Sangamo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
160213965151,0932,207
Upgrade
Market Cap Growth
78.66%120.88%-81.28%-52.90%-50.50%127.45%
Upgrade
Enterprise Value
145201-12046141,554
Upgrade
Last Close Price
0.531.020.543.147.5015.61
Upgrade
PS Ratio
1.453.680.554.629.8718.68
Upgrade
PB Ratio
7.389.351.161.752.914.44
Upgrade
P/TBV Ratio
8.169.351.162.493.885.56
Upgrade
P/FCF Ratio
-----14.23
Upgrade
P/OCF Ratio
-----12.99
Upgrade
EV/Sales Ratio
1.783.48-1.835.5413.15
Upgrade
EV/FCF Ratio
-----10.01
Upgrade
Debt / Equity Ratio
1.201.340.460.150.130.09
Upgrade
Debt / FCF Ratio
-----0.27
Upgrade
Asset Turnover
0.860.430.480.170.130.15
Upgrade
Quick Ratio
0.911.021.782.532.994.51
Upgrade
Current Ratio
1.051.131.982.693.124.60
Upgrade
Return on Equity (ROE)
-292.47%-185.39%-136.47%-57.37%-40.86%-26.05%
Upgrade
Return on Assets (ROA)
-41.15%-46.05%-19.63%-19.59%-13.80%-10.27%
Upgrade
Return on Capital (ROIC)
-81.82%-70.52%-31.12%-33.04%-23.80%-15.93%
Upgrade
Earnings Yield
-39.58%-46.02%-267.59%-37.37%-16.32%-5.48%
Upgrade
FCF Yield
-22.62%-31.67%-255.31%-47.38%-23.48%7.03%
Upgrade
Buyback Yield / Dilution
-20.61%-15.62%-13.02%-6.76%-7.53%-19.92%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q